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STUDY ON THE PREVALENCE OF BETA LACTAMASES IN 
GRAM NEGATIVE CLINICAL ISOLATES 
ABSTRACT 
BACKGROUND:   
 Antimicrobial resistance is really a threat to clinical practice. Bacteria develop 
various mechanisms of resistance to different group of antibiotics. Antimicrobial 
resistance is the resistance of a microorganism to an antimicrobial drug that was 
originally effective for treatments of infections caused by it, by acquiring genes 
coding for it the consequences of antibiotic resistance lead to longer duration of 
illness, treatment with expensive drugs, higher mortality and increased burden on the 
health system. The predominant mechanism for resistance to beta lactam antibiotics is 
production of beta lactamases. 
AIM:  
 The present study aims to find out the various β lactamases producing gram 
negative bacteria from the samples received from outpatients and inpatients admitted 
in our hospital.   
MATERIALS AND METHODS:             
 A prospective study was conducted from April 2014 to March 2015   in the 
department of Microbiology, Karpaga Vinayaga Institute of Medical Sciences and 
Research Centre, Kancheepuram district. Those who were resistant to one of the 3 rd 
generation cephalosporin were selected as suspicious beta lactamase producer. These 
isolates were subjected to confirmatory test for ESBL , Amp C and Carbapenamases 
and MBL. 
RESULTS:  
 
 492 gram negative samples were obtained during the study period (April 
2014 to March 2015), among which 204 isolates showing resistance to one of 
the III generation cephalosporins, were taken for beta lactamase detection. 
  
 The prevalence of beta lactamase production in   GNB   in our study was found 
to be 41.4%.Total   ESBL producer was 32.94%. The occurrence of   beta lactamases 
producers in various isolates in this study showed, that E.coli   was the common ESBL 
producer. Total Amp C production was   14.22%. The major Amp c producer was 
Klebsiella species. Total MBL production was 5.48%, which is very low when 
compared to other  similar studies. The distribution of the combinations was as 
follows, 118 strains produced only ESBL (118/162).  The combinations like ( ESBL 
+AmpC ) were found in 31 strains (31/162  ), (ESBL +MBL)was found in three 
strains ( 03/162) , and ESBL with AmpC and carbapenemase  was seen  in 10 strains ( 
10/ 162). Similarly Amp C coexisted with MBL in 2 strains. 
 
CONCLUSION:  
 The study conducted in our hospital highlights the emerging   prevalence of 
beta lactamases hence reporting of beta lactamases   production along with routine 
antibiotic susceptibility testing in every lab should be done, in order to guide the 
physicians to choose the appropriate antibiotics. All attempts should be made to 
prevent dissemination of beta lactamases in the community. 
